Impact of Medical Operability and Total Metastatic Ablation on Outcomes After SABR for Oligometastases
Shankar Siva, Gavin Jones, Mathias Bressel, Mark Shaw, Sarat Chander, Julie Chu, Nikki Plumridge, Keelan Byrne, Gargi Kothari, Nicholas Hardcastle, Mathieu Gaudreault, Tomas Kron, Greg Wheeler, Michael MacManus, Gerard G. Hanna, David Ball, Steven David
Topics & Concepts
MedicineSABR volatility modelCommon Terminology Criteria for Adverse EventsAdverse effectAblationInternal medicineSurgeryOncologyVolatility (finance)Financial economicsStochastic volatilityEconomicsManagement of metastatic bone diseaseHepatocellular Carcinoma Treatment and PrognosisLung Cancer Diagnosis and Treatment